Texas will recover nearly $34 million from AstraZeneca Pharmaceuticals LP under a settlement resolving allegations that the drugmaker used an illegal kickback scheme to influence prescriptions covered by the state’s Medicaid program.
The settlement requires AstraZeneca to pay $33,998,000 to resolve claims brought under the Texas Health Care Program Fraud Prevention Act, according to the Texas Attorney General’s Office.
The agreement resolves the state’s claims that AstraZeneca improperly induced health care providers to prescribe its medications, resulting in millions of dollars in Texas Medicaid claims.
According to the attorney general’s office, AstraZeneca provided free nursing services and reimbursement support to prescribers and paid third parties to deploy nurses and other health care professionals to medical providers.